4.1 Article

Factors Associated With Experiences of Genetic Discrimination Among Individuals at Risk for Huntington Disease

出版社

WILEY
DOI: 10.1002/ajmg.b.31130

关键词

genetic discrimination; Huntington disease; genetic testing; socio-demographic factors

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. National Institutes of Health, National Institute of Neurological Disorders and Stroke [3 R01 NS040068]
  3. Michael Smith Foundation for Health Research/Child and Family Research Institute
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040068] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The purpose of this study was to identify factors that are associated with experiencing genetic discrimination (GD) among individuals at risk for Huntington disease (HD). Multivariable logistic regression analysis was used to examine factors associated with experiencing GD in data from a cross-sectional, self-report survey of 293 individuals at risk for HD. The study sample comprised 167 genetically tested respondents, and 66 who were not tested (80% response rate). Overall, individuals who learn they are at risk for HD at a younger age (OR 3.1; 95% CI: 1.5-6.2; P = 0.002), are mutation-positive (OR 2.8; 95% CI: 1.4-6.0; P = 0.006), or are highly educated (OR 2.7; 95% CI: 1.4-5.1; P = 0.002) are more likely to experience GD, particularly in insurance, family, and social settings. Further, younger age was associated with discrimination in insurance(OR 0.97; 95% CI: 0.94-1.00; P = 0.038). This study provides evidence that some people who are at risk for HD were more likely to experience GD than others. Individuals who learned they are at risk for HD at a younger age and those who are mutation-positive were more likely to experience GD, particularly in insurance, family, and social settings. Younger individuals were more likely to experience discrimination in the insurance setting. Overall, highly educated individuals were also more likely to report discrimination. These results provide direction for clinical and family discussions, counseling practice, and policy aimed at mitigating experiences of GD. (C) 2010 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Utilization of telehealth in paediatric genome-wide sequencing: Health services implementation issues in the CAUSES Study

Alison M. Elliott, Nick Dragojlovic, Teresa Campbell, Shelin Adam, Christele du Souich, Michele Fryer, Anna Lehman, Clara van Karnebeek, Larry D. Lynd, Jan M. Friedman

Summary: Genome-wide sequencing is revolutionizing the care of pediatric patients with rare diseases, with genetic counselling recommended for families undergoing this procedure. Telehealth has enabled access to genome-wide sequencing for families in remote areas, but has led to delays in sample accrual.

JOURNAL OF TELEMEDICINE AND TELECARE (2023)

Article Biochemistry & Molecular Biology

Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease

Ligia Fao, Patricia Coelho, Luis Duarte, Rita Vilaca, Michael R. Hayden, Sandra I. Mota, Ana Cristina Rego

Summary: This study demonstrates that c-Src/Fyn proteins play an important role in controlling mitochondrial function and redox regulation in Huntington's disease (HD). Restoring c-Src/Fyn levels in HD improves mitochondrial morphology and function, reducing the levels of oxidant species and cell death. These findings suggest that c-Src/Fyn could be a potential therapeutic target for HD.

ANTIOXIDANTS & REDOX SIGNALING (2023)

Article Biology

Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models

Pawel Joachimiak, Adam Ciesiolka, Emilia Kozlowska, Pawel M. Switonski, Grzegorz Figura, Agata Ciolak, Grazyna Adamek, Magdalena Surdyka, Zaneta Kalinowska-Poska, Maciej Figiel, Nicholas S. S. Caron, Michael R. R. Hayden, Agnieszka Fiszer

Summary: This study used SNP variants to quantitatively determine the allele-specific expression levels in patient-derived cell lines for spinocerebellar ataxia type 3 (SCA3) and Huntington's disease (HD). They found differences in allele expression levels and developed a reliable and quantitative method using SNP-based droplet digital PCR (ddPCR) to analyze low abundant transcripts. This allele-selective approach provides insights into allele-related mechanisms and can improve understanding of polyglutamine diseases.

BMC BIOLOGY (2023)

Article Genetics & Heredity

Finding the sweet spot: a qualitative study exploring patients' acceptability of chatbots in genetic service delivery

Stephanie Luca, Marc Clausen, Angela Shaw, Whiwon Lee, Suvetha Krishnapillai, Ella Adi-Wauran, Hanna R. Faghfoury, Gregory Costain, Rebekah Jobling, Melyssa Aronson, Eriskay Liston, Josh Silver, Cheryl Shuman, Lauren Chad, Robin Hayeems, Yvonne J. Bombard, Genetics Navigator Study Team

Summary: This study investigated the preferences of individuals who underwent genetic testing for using chatbots. It found that chatbots were considered inefficient for very simple and very complex tasks, but acceptable for moderately complex tasks. Participants also expressed the need for a safety net (access to a clinician) for unaddressed needs. These findings can inform the implementation of chatbots in genomic medicine.

HUMAN GENETICS (2023)

Article Physiology

Full-length huntingtin is palmitoylated at multiple sites and post-translationally myristoylated following caspase-cleavage

Fanny L. Lemarie, Shaun S. Sanders, Yen Nguyen, Dale D. O. Martin, Michael R. Hayden

Summary: Huntington's disease is a neurodegenerative disorder caused by CAG repeat expansion in the HTT gene. We found that huntingtin protein can be palmitoylated at cysteine 214, and proteolytic cleavage at aspartate 552 leads to myristoylation at glycine 553. Blocking caspase cleavage at aspartate 586 increases myristoylation of huntingtin and promotes the interaction between C-terminal and N-terminal fragments.

FRONTIERS IN PHYSIOLOGY (2023)

Article Neurosciences

Chronic multiscale resolution of mouse brain networks using combined mesoscale cortical imaging and subcortical fiber photometry

Daniel Ramandi, Nicholas J. Michelson, Lynn A. Raymond, Timothy H. Murphy

Summary: This study developed a method for simultaneous mesoscale cortical imaging and subcortical fiber photometry recording, which allows the study of neuronal activity. The results showed a high correlation between cortical and striatal activity in response to sensory stimulation or movement. This method can provide insights into the cell-specific connectivity in the corticobasal ganglia circuit organization.

NEUROPHOTONICS (2023)

Editorial Material Developmental Biology

Bob Brent: Medical expert, expert medical witness, and expert on medical expert witnessing

Jan M. Friedman

BIRTH DEFECTS RESEARCH (2023)

Article Neurosciences

Water-Reaching Platform for Longitudinal Assessment of Cortical Activity and Fine Motor Coordination Defects in a Huntington Disease Mouse Model

Yundi Wang, Marja D. Sepers, Dongsheng Xiao, Lynn A. Raymond, Timothy H. Murphy

Summary: This study developed a high-throughput water-reaching task and training protocol to monitor forelimb impairment and cortical changes in HD mice. The results showed that HD mice took longer to learn the event sequence and displayed reduced cortical activity associated with successful reaches. Over time, cortical activity increased and reaching trajectories became longer and more variable in HD mice. This study provides insights into the onset and manifestation of movement disorders, therapeutic intervention windows, and testing of drug efficacy.

ENEURO (2023)

Article Neurosciences

Axonal ER Ca2+ Release Selectively Enhances Activity-Independent Glutamate Release in a Huntington Disease Model

James P. Mackay, Amy I. Smith-Dijak, Ellen T. Koch, Peng Zhang, Evan Fung, Wissam B. Nassrallah, Caodu Buren, Mandi Schmidt, Michael R. Hayden, Lynn A. Raymond

Summary: Miniature neurotransmission is increased in the Huntington disease (HD) model, associated with abnormal endoplasmic reticulum (ER) calcium handling. These abnormalities influence neurotransmission indirectly, without direct ER calcium release into the cytoplasm. However, in cortical cultures and brain slices, there are no significant differences in calcium release between the HD-model neurons and wild-type cells.

JOURNAL OF NEUROSCIENCE (2023)

Article Clinical Neurology

Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose

Borje Darpo, Michal Geva, Georg Ferber, Yigal Paul Goldberg, Andres Cruz-Herranz, Munish Mehra, Richard Kovacs, Michael R. Hayden

Summary: Pridopidine, a selective sigma-1 receptor agonist, shows a favorable cardiac safety profile at the therapeutic dose of 45 mg bid, with no clinically relevant effect on the QT interval.

NEUROLOGY AND THERAPY (2023)

Article Public, Environmental & Occupational Health

Does obesity related eating behaviors only affect chronic diseases? A nationwide study of university students in China

Sihui Peng, Dan Wu, Tingzhong Yang, Joan L. Bottorff

Summary: The purpose of this study was to examine the associations between obesity-related eating behaviors (OEB) and chronic and infectious diseases, as well as mental disorders. A nationwide survey was conducted among 11,659 medical students from 31 universities in China, and multiple variable logistic regression analysis was used to analyze the associations. The results showed significant associations between OEB and chronic disease, infectious disease, and mental disorder. These findings highlight the importance of addressing OEB in health promotion and disease prevention programs and policies among university students.

PREVENTIVE MEDICINE REPORTS (2023)

Article Biotechnology & Applied Microbiology

Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders

Fabio Duarte, Gabriel Vachey, Nicholas S. Caron, Melanie Sipion, Maria Rey, Anselme L. Perrier, Michael R. Hayden, Nicole Deglon

Summary: Huntington's disease is a fatal neurodegenerative disorder that can be treated by inactivating the mutated HTT gene. One approach to selectively inactivate the mutant allele is by using the CRISPR/Cas9 system to remove the first exon of the mutated HTT. However, the frequency of deletion events is still uncertain.

HUMAN GENE THERAPY (2023)

Article Clinical Neurology

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Erin Furr Stimming, Daniel Claassen, Elise Kayson, Jody Goldstein, Raja Mehanna, Hui Zhang, Grace S. Liang, Dietrich Haubenberger

Summary: Valbenazine was evaluated as a treatment for chorea associated with Huntington's disease, and it was found to be more effective than placebo in improving chorea symptoms and well tolerated.

LANCET NEUROLOGY (2023)

Article Genetics & Heredity

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb H. Yohay, Justin T. Jordan, Scott R. Plotkin, Robert J. Allaway, Jaishri O. Blakeley

Summary: This study investigated whether patients with rare diseases such as neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), or schwannomatosis (SWN) are more susceptible to SARS-CoV-2 infection and severe COVID-19. The results showed that the proportion of positive cases in NF1, NF2, or SWN patients was not significantly higher than in individuals without these rare diseases. There were no severe outcomes reported in the NF2 or SWN cohorts, and the proportion of severe outcomes in NF1 patients was similar to other rare disease cohorts and the general population.

GENETICS IN MEDICINE (2023)

暂无数据